Cue Biopharma, Inc. SEC filings CUE
Cue Biopharma, Inc. has 552 filings in SEC EDGAR's recent list, going back to Jun 19, 2015. Its latest annual report, Form ARS, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 21, 2026 (regulation fd disclosure, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Oct 14, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Oct 14, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Oct 14, 2026 | Oct 12, 2026 |
| 144 | Notice of proposed sale | Oct 13, 2026 | — |
| 144 | Notice of proposed sale | Oct 13, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 8, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 21, 2026 | Sep 20, 2026 |
| 4/A | Filing | Aug 28, 2026 | Jul 9, 2026 |
| 4/A | Filing | Aug 28, 2026 | Jul 9, 2026 |
| SCHEDULE 13D | Ownership over 5% (active) | Aug 21, 2026 | — |
| EFFECT | Filing | Aug 20, 2026 | — |
| CORRESP | Letter to the SEC | Aug 18, 2026 | — |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| 4 | Insider transaction | Aug 17, 2026 | Aug 13, 2026 |
| UPLOAD | Letter from the SEC | Aug 17, 2026 | — |
| 4 | Insider transaction | Aug 14, 2026 | Aug 12, 2026 |
| 144 | Notice of proposed sale | Aug 14, 2026 | — |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 14, 2026 | — |
| 144 | Notice of proposed sale | Aug 13, 2026 | — |
| S-3 | Shelf registration | Aug 12, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Aug 3, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Aug 3, 2026 | Jul 30, 2026 |
| 3 | Initial insider ownership | Aug 3, 2026 | Jul 30, 2026 |
| 4/A | Filing | Jul 30, 2026 | Jun 1, 2026 |
| D | Filing | Jul 22, 2026 | — |
| 4 | Insider transaction | Jul 15, 2026 | Jul 13, 2026 |
| 3 | Initial insider ownership | Jul 15, 2026 | Jul 13, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 4 | Insider transaction | Jul 10, 2026 | Jul 9, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
Jul 10, 2026 | Jul 9, 2026 |
| EFFECT | Filing | Jul 1, 2026 | — |
| CORRESP | Letter to the SEC | Jun 29, 2026 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2026 | — |
| S-3 | Shelf registration | Jun 18, 2026 | — |
| EFFECT | Filing | Jun 17, 2026 | — |
| CORRESP | Letter to the SEC | Jun 15, 2026 | — |
| 3 | Initial insider ownership | Jun 11, 2026 | Jun 1, 2026 |
| 3 | Initial insider ownership | Jun 11, 2026 | Jun 1, 2026 |
| UPLOAD | Letter from the SEC | Jun 10, 2026 | — |
| 4 | Insider transaction | Jun 8, 2026 | May 30, 2026 |
| 3 | Initial insider ownership | Jun 8, 2026 | May 30, 2026 |
| 4 | Insider transaction | Jun 3, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 3, 2026 | Jun 1, 2026 |
| S-8 | Employee stock plan registration | Jun 3, 2026 | — |
| S-3 | Shelf registration | Jun 3, 2026 | — |
| 4 | Insider transaction | Jun 2, 2026 | May 30, 2026 |
| 3 | Initial insider ownership | Jun 2, 2026 | May 30, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 2, 2026 | May 29, 2026 |
| DEF 14A | Proxy statement | May 21, 2026 | Jun 1, 2026 |
| 8-K | Current report | May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| D | Filing | May 14, 2026 | — |
| PRE 14A | Preliminary proxy statement | May 11, 2026 | Jun 1, 2026 |
| 3 | Initial insider ownership | May 7, 2026 | Apr 30, 2026 |
| 4 | Insider transaction | May 7, 2026 | May 3, 2026 |
| S-8 | Employee stock plan registration | May 1, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Other events
|
May 1, 2026 | Apr 27, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Apr 22, 2026 | Apr 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Apr 13, 2026 | Apr 13, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 4 | Insider transaction | Apr 10, 2026 | Apr 9, 2026 |
| 8-K |
Current report
Other events
|
Apr 7, 2026 | Apr 1, 2026 |
| EFFECT | Filing | Mar 31, 2026 | — |
| CORRESP | Letter to the SEC | Mar 27, 2026 | — |
| DEFA14A | Additional proxy material | Mar 27, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Mar 27, 2026 | Mar 23, 2026 |
| UPLOAD | Letter from the SEC | Mar 23, 2026 | — |
| S-3 | Shelf registration | Mar 16, 2026 | — |
| ARS | Annual report to shareholders | Mar 16, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Mar 16, 2026 | Mar 16, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 16, 2026 | Mar 16, 2026 |
| 10-K | Annual report | Mar 16, 2026 | Dec 31, 2025 |
| PRE 14A | Preliminary proxy statement | Mar 6, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Other events
|
Feb 18, 2026 | Feb 18, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 12, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| 4 | Insider transaction | Jan 2, 2026 | Dec 30, 2025 |
| 144 | Notice of proposed sale | Dec 29, 2025 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 424B5 | Prospectus supplement | Dec 19, 2025 | — |
| 424B5 | Prospectus supplement | Dec 18, 2025 | — |
| 4 | Insider transaction | Dec 5, 2025 | Sep 26, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Sep 29, 2025 |
| 4 | Insider transaction | Nov 25, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 24, 2025 | Nov 24, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 20, 2025 | Nov 17, 2025 |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Nov 6, 2025 | Nov 6, 2025 |
| 4 | Insider transaction | Oct 2, 2025 | Sep 29, 2025 |
| 3 | Initial insider ownership | Oct 2, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 29, 2025 | Sep 26, 2025 |
| S-8 | Employee stock plan registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Material agreement
|
Jul 1, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 4, 2025 |
| 3 | Initial insider ownership | Jun 6, 2025 | Jun 4, 2025 |
| DEFA14A | Additional proxy material | May 27, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 16, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 25, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 25, 2025 | Jun 3, 2025 |
| DEFA14A | Additional proxy material | Apr 25, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Other events
|
Apr 15, 2025 | Apr 14, 2025 |
| 424B5 | Prospectus supplement | Apr 15, 2025 | — |
| 424B5 | Prospectus supplement | Apr 14, 2025 | — |
| 8-K |
Current report
Material agreement
|
Apr 14, 2025 | Apr 10, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 14, 2025 | Apr 14, 2025 |
| S-8 | Employee stock plan registration | Mar 31, 2025 | — |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 21, 2025 | — |
| 8-K |
Current report
Officer or director change
|
Mar 12, 2025 | Mar 10, 2025 |
| 4 | Insider transaction | Mar 12, 2025 | Mar 10, 2025 |
| 3 | Initial insider ownership | Mar 12, 2025 | Mar 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Jan 2, 2025 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| UPLOAD | Letter from the SEC | Dec 16, 2024 | — |
| CORRESP | Letter to the SEC | Dec 11, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 5, 2024 | — |
| 4 | Insider transaction | Nov 29, 2024 | Nov 25, 2024 |
| 3 | Initial insider ownership | Nov 29, 2024 | Nov 25, 2024 |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Oct 8, 2024 | Oct 8, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 7, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 4, 2024 | Oct 2, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 27, 2024 | Sep 26, 2024 |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 424B5 | Prospectus supplement | Sep 26, 2024 | — |
| DEF 14A | Proxy statement | Sep 10, 2024 | Oct 8, 2024 |
| 3 | Initial insider ownership | Sep 5, 2024 | Sep 3, 2024 |
| 4 | Insider transaction | Sep 5, 2024 | Sep 3, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 3, 2024 | Aug 28, 2024 |
| PRE 14A | Preliminary proxy statement | Aug 28, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Listing notice
|
Aug 16, 2024 | Aug 15, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jul 25, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| 3 | Initial insider ownership | Jun 7, 2024 | Jun 5, 2024 |
| 4 | Insider transaction | Jun 7, 2024 | Jun 5, 2024 |
| DEFA14A | Additional proxy material | May 24, 2024 | — |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 5, 2024 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| S-8 | Employee stock plan registration | Mar 28, 2024 | — |
| 10-K | Annual report | Mar 28, 2024 | Dec 31, 2023 |
| SC 13G | Ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Feb 22, 2024 | Feb 20, 2024 |
| SC 13G | Ownership over 5% (passive) | Feb 7, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Jan 31, 2024 | — |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 4 | Insider transaction | Jan 4, 2024 | Jan 2, 2024 |
| 10-Q | Quarterly report | Nov 3, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Sep 14, 2023 | Sep 12, 2023 |
| 4 | Insider transaction | Aug 29, 2023 | Aug 25, 2023 |
| 4 | Insider transaction | Aug 16, 2023 | Aug 14, 2023 |
| 10-Q | Quarterly report | Aug 8, 2023 | Jun 30, 2023 |
| 4 | Insider transaction | Jul 25, 2023 | Jul 21, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CUE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Somerville, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1645460
- Former names
- Imagen Biopharma, Inc. (until Jun 19, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.